Regenerex Pharma (RGPX) Restructuring Costs (2012 - 2014)

Regenerex Pharma (RGPX) has 3 years of Restructuring Costs data on file, last reported at $825.0 in Q3 2014.

• Restructuring Costs for Q3 2014 came in at $825.0, down 52.99% year-over-year; the trailing twelve-month figure through Aug 2014 was $32786.0 (changed N/A YoY), and the FY2013 annual result was $30350.0, up 87.05% from the prior year.
• Restructuring Costs fell to $825.0 in Q3 2014 per RGPX's latest filing, from $28266.0 in the prior quarter.
• Over five years, Restructuring Costs peaked at $28266.0 in Q4 2013 and troughed at $825.0 in Q3 2014.
• A 3-year average of $6746.6 and a median of $1755.0 in 2013 frame the typical range for Restructuring Costs.
• The sharpest annual moves came in 2013 and 2014: Restructuring Costs jumped 104.86% in 2013, then tumbled 52.99% in 2014.
• A 3-year view of Restructuring Costs shows it stood at $947.0 in 2012, then jumped by 2884.79% to $28266.0 in 2013, then sank by 97.08% to $825.0 in 2014.
• Business Quant data shows RGPX's Restructuring Costs at $825.0 in Q3 2014, $28266.0 in Q4 2013, and $1755.0 in Q3 2013.